Identifying technology clusters based on automated patent landscaping
PLOS ONE · 14.12.2023 · 18 (12) · e0295587
DOI: 10.1371/journal.pone.0295587 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 14.12.2023. Verfasst von Bergeaud Antonin und 1 weiteren Autor:innen. Beteiligte Einrichtung: HEC Paris, Paris, France. Hauptthemen laut MEDLINE: Technology, Gene Editing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We introduce a new general methodological approach for accurately and consistently retrieving a large set of patents related to specific technologies. We build upon the automated patent landscaping algorithm by incorporating a tractable amount of human supervision to improve the accuracy and consistency of our results. We demonstrate the efficacy of our approach by applying it to six novel and representative technologies: additive manufacturing, blockchain, computer vision, genome editing, hydrogen storage, and self-driving vehicles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- HEC Paris, Paris, France.
- Centre for Economic Policy, London, United Kingdom.
- Center for Economic and Policy Research, Paris, France.
- Paris School of Economics, Paris, France.
- College de France, Paris, France.
ORCID-Profile: Bergeaud Antonin
Zitieren
APA
Antonin, B., & Cyril, V. (2023). Identifying technology clusters based on automated patent landscaping. PLOS ONE, 18(12), e0295587. https://doi.org/10.1371/journal.pone.0295587
Vancouver
Antonin B, Cyril V. Identifying technology clusters based on automated patent landscaping. PLOS ONE. 2023;18(12):e0295587. doi:10.1371/journal.pone.0295587
BibTeX
@article{Antonin2023,
author = {Antonin, Bergeaud and Cyril, Verluise},
title = {Identifying technology clusters based on automated patent landscaping},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {12},
pages = {e0295587},
doi = {10.1371/journal.pone.0295587}
}
EUVIMED